---
figid: PMC8156937__life-11-00440-g002
figtitle: Molecular Mechanisms of Action of Novel Psychoactive Substances (NPS). A
  New Threat for Young Drug Users with Forensic-Toxicological Implications
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC8156937
filename: life-11-00440-g002.jpg
figlink: /pmc/articles/PMC8156937/figure/life-11-00440-f002/
number: F2
caption: 'Modified from Guzman et al. Cannabinoids: Potential anticancer agents. Nat
  Rev Cancer. Mechanism activated by the receptor of human cannabinoids 1 (CB1R),
  ranging from binding to G-protein-coupled receptors (Gi/o) with inhibition of the
  adenylyl cyclase (AdeC), and therefore of the cyclicAMP (cAMP) and of the protein
  kinase A (PKA). Inhibition of voltage-sensitive Ca2+ channels (VSCC); release of
  Ca2+ from intracellular stores; activation of the phosphatidylinositol 3-kinase
  (PI3K)–AKT pathway; activation of mitogen-activated protein kinase cascades as extracellular-signal-regulated
  kinase (ERK), JUN amino-terminal kinase (JNK), and p38 and ceramide generation through
  FAN–sphingomyelinase (factor associated with neutral sphingomyelinase activation–SMase).'
papertitle: Molecular Mechanisms of Action of Novel Psychoactive Substances (NPS).
  A New Threat for Young Drug Users with Forensic-Toxicological Implications.
reftext: Arianna Giorgetti, et al. Life (Basel). 2021 May;11(5):440.
year: '2021'
doi: 10.3390/life11050440
journal_title: Life
journal_nlm_ta: Life (Basel)
publisher_name: MDPI
keywords: forensic toxicology | new psychoactive substances (NPS) | mass spectrometry
  | toxicodynamic | mechanism of action
automl_pathway: 0.843436
figid_alias: PMC8156937__F2
figtype: Figure
redirect_from: /figures/PMC8156937__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8156937__life-11-00440-g002.html
  '@type': Dataset
  description: 'Modified from Guzman et al. Cannabinoids: Potential anticancer agents.
    Nat Rev Cancer. Mechanism activated by the receptor of human cannabinoids 1 (CB1R),
    ranging from binding to G-protein-coupled receptors (Gi/o) with inhibition of
    the adenylyl cyclase (AdeC), and therefore of the cyclicAMP (cAMP) and of the
    protein kinase A (PKA). Inhibition of voltage-sensitive Ca2+ channels (VSCC);
    release of Ca2+ from intracellular stores; activation of the phosphatidylinositol
    3-kinase (PI3K)–AKT pathway; activation of mitogen-activated protein kinase cascades
    as extracellular-signal-regulated kinase (ERK), JUN amino-terminal kinase (JNK),
    and p38 and ceramide generation through FAN–sphingomyelinase (factor associated
    with neutral sphingomyelinase activation–SMase).'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Pka-C1
  - Pka-R2
  - Pka-C3
  - Pka-R1
  - Pka-C2
  - Ada
  - AP-2alpha
  - Go
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Akt
  - fan
  - de
  - CG32052
  - lic
  - p38b
  - Nurf-38
  - Ebp
  - AIMP2
  - p38a
  - Hrb87F
  - p38c
  - bsk
  - Erk7
  - rl
  - sm
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - ADA
  - ADAD1
  - ADAD2
  - ADAR
  - ADARB1
  - ADARB2
  - ADAT1
  - ADAT2
  - ADAT3
  - GNAO1
  - GNAI1
  - GNAI2
  - GNAI3
  - GNAT1
  - GNAT2
  - GNAT3
  - GNAZ
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - CNR1
  - NSMAF
  - CNTRL
  - CRK
  - MAPK14
  - MAPK1
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK8
  - MAPK9
  - MAPK10
  - EPHB2
  - MAPK3
---
